# US 2015/0105299 A1 · Method for Differentiation of Polynucleotide Strands

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2015/0105299 A1
- Document ID: US20150105299A1
- Status: Published application
- Kind: A1
- Application number: 14/546,844
- Filed: 2014-11-18
- Published: 2015-04-16
- Earliest claimed: 2009-07-06
- Assignees: Max-Planck-Gesellschaft zur Forderung der Wissenschaften e.V.
- Applicants: Max-Planck-Gesellschaft Zur Forderung Der Wissenschaften E.V.
- Inventors: Aleksey Soldatov; Tatiana Borodina; Hans Lehrach
- Web page: https://patentgrep.com/patent/US20150105299A1

## CPC

- C12Q 1/6869: Methods for sequencing
- C12Q 1/6848: characterised by the means for preventing contamination or increasing the specificity or sensitivity of an amplification reaction
- C12Q 1/6853: using modified primers or templates
- C12Q 1/6855: Ligating adaptors
- C12Q 1/6876: Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q: MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS (immunoassay G01N33/53); COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES

## Abstract

Objective of the present invention is to provide a method for keeping of directional information in double-stranded DNA. We suggest to convert polynucleotide into a hybrid double-stranded DNA. One particular strand of this hybrid double-stranded DNA should be synthesised using at least one modified nucleotide. Thus, this particular strand would contain modified nucleotides along the whole length. Density of directional markers would not depend on the length of polynucleotides. Any internal fragments of the hybrid double-stranded DNA would have directional information. When it is necessary the modified strand may be easily degraded or separated from the other strand. It was found that such hybrid double-stranded DNA may be easily generated in a number of molecular biology tasks and may be used for molecular cloning, library preparation and strand separation.

## Claims

### Claim at position 1

1-16. (canceled)

### Claim 17

A method for preparing a nucleic acid molecule for strand-specific sequencing, comprising:
(a) producing a double-stranded DNA by:
(i) reverse transcribing an RNA to make a first DNA strand; and
(ii) copying the first DNA strand in the presence of a dUTP to make a second DNA strand comprising one or more deoxyuridines;
(b) amplifying, by PCR, at least part of the first DNA strand but not the second DNA strand of the double-stranded DNA by:
(i) subjecting the product of step (a) or a fragment thereof to amplification using a polymerase that is suppressed by a template comprising deoxyuridine; and/or
(ii) treating the product of step (a) or a fragment thereof with uracil-N-glycosylase (UDG) to remove uracil from the second strand and then amplifying the UDG-treated product using a polymerase.

### Claim 18 (depends on 17)

The method of claim 17, wherein the RNA of step (a)(i) is produced by fragmenting an initial RNA sample.

### Claim 19 (depends on 17)

The method of claim 17, wherein the method comprises fragmenting the double-stranded DNA of step (a) to produce DNA fragments, prior to step (b).

### Claim 20 (depends on 19)

The method of claim 19, wherein the fragmenting comprises sonicating or enzymatically digesting the double-stranded DNA.

### Claim 21 (depends on 17)

The method of claim 17, wherein the method further comprises at step (a) ligating adaptors to the double-stranded DNA, or a fragment thereof, prior to step (b).

### Claim 22 (depends on 21)

The method of claim 21, wherein the ligating comprises attaching different adaptor sequences to the 5′ and 3′ ends of the first DNA strand in the double-stranded DNA or fragment thereof.

### Claim 23 (depends on 22)

The method of claim 22, wherein the method comprises ligating a Y adaptor to the double-stranded DNA, or a fragments thereof, prior to step (b).

### Claim 24 (depends on 17)

The method of claim 17, wherein the reverse transcribing step (a)(i) is done using an oligo(dT) primer or a random primer.

### Claim 25 (depends on 17)

The method of claim 17, wherein the reverse transcribing step (a)(i) is done using a reverse transcriptase selected from the group consisting of: human immune deficiency virus 1 reverse transcriptase, Moloney murine leukemia virus reverse transcriptase, avian myeloblastosis virus reverse transcriptase, telomerase reverse transcriptase, or a functional variant thereof.

### Claim 26 (depends on 17)

The method of claim 17, wherein the copying step (a)(ii) is done in the presence of a dUTP and RNaseH to make a second DNA strand comprising one or more deoxyuridines.

### Claim 27 (depends on 17)

The method of claim 17, wherein the method comprises:
(a) producing the double-stranded DNA by:
(i) reverse transcribing an RNA to make a first DNA strand;
(ii) copying the first DNA strand in the presence of a dUTP and RNaseH to make a second DNA strand comprising one or more deoxyuridines;
(iii) fragmenting the product of step (ii) by sonication to produce fragments;
(iv) end-polishing the fragments; and
(v) ligating adaptors to the end-polished fragments;
(b) amplifying, by PCR, at least part of the first DNA strand but not the second DNA strand of the double-stranded DNA by:
(i) treating the product of step (a) with uracil-N-glycosylase (UDG) to remove uracil from the second strand;
(ii) heating the UDG-treated DNA to degrade the second DNA strand; and
(iii) amplifying the first DNA strand using a polymerase and one or more primers that hybridize to the adaptors added in (a)(v).

### Claim 28 (depends on 17)

The method of claim 17, wherein the method comprises:
(a) producing a double-stranded DNA by:
(i) fragmenting an initial RNA sample;
(ii) reverse transcribing the fragmented RNA to make a first DNA strand;
(iii) copying the first DNA strand in the presence of a dUTP to make a second DNA strand comprising one or more deoxyuridines;
(iv) A-tailing the product of step (iii); and
(v) ligating an adaptor to the A-tailed product of (iv);
(b) amplifying, by PCR, at least part of the first DNA strand but not the second DNA strand of the double-stranded DNA by subjecting the product of step (a) to amplification using a polymerase that is suppressed by a template comprising deoxyuridine and one or more primers that hybridize to the adaptor added in (a)(v).

### Claim 29 (depends on 17)

The method of claim 17, wherein the method comprises:
(a) producing a double-stranded DNA by:
(i) fragmenting an initial RNA sample;
(ii) reverse transcribing the fragmented RNA to make a first DNA strand;
(iii) copying the first DNA strand in the presence of a dUTP to make a second DNA strand comprising one or more deoxyuridines;
(iv) A-tailing the product of step (iii); and
(v) ligating adaptors to the A-tailed product of (iv);
(b) amplifying, by PCR, at least part of the first DNA strand but not the second DNA strand of the double-stranded DNA by treating the product of step (a) with uracil-N-glycosylase (UDG) to remove uracil from the second strand and then amplifying the UDG-treated product using a polymerase and one or more primers that hybridize to the adaptor added in (a)(v).
